The estimated Net Worth of Ronald J Daniels is at least 291 千$ dollars as of 28 December 2021. Mr. Daniels owns over 22,147 units of BridgeBio Pharma Inc stock worth over 291,152$ and over the last 5 years he sold BBIO stock worth over 0$. In addition, he makes 0$ as Independent Director at BridgeBio Pharma Inc.
Ronald has made over 1 trades of the BridgeBio Pharma Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 22,147 units of BBIO stock worth 298,763$ on 28 December 2021.
The largest trade he's ever made was buying 22,147 units of BridgeBio Pharma Inc stock on 28 December 2021 worth over 298,763$. On average, Ronald trades about 3,691 units every 0 days since 2020. As of 28 December 2021 he still owns at least 10,402 units of BridgeBio Pharma Inc stock.
You can see the complete history of Mr. Daniels stock trades at the bottom of the page.
Ronald J. Daniels serves as Independent Director of the Company. Mr. Daniels has been the president of Johns Hopkins University since March 2009. He is a member of the Board of Managers of the Johns Hopkins Applied Physics Laboratory and the chair of the Executive Committee of Johns Hopkins Health System. A law and economics scholar, Mr. Daniels is author or editor of seven books and dozens of scholarly articles. Before joining Johns Hopkins University, he served as Provost and a Professor of Law at the University of Pennsylvania and Dean and James M. Tory Professor of Law of the Faculty of Law at the University of Toronto. Mr. Daniels earned an L.L.M. from Yale University in 1988 and a J.D. in 1986 from the University of Toronto. He received a B.A. from the University of Toronto in 1982 in political science and economics. Mr. Daniels’ qualifications to serve on our Board of Directors include his extensive experience as a professor and now a leader at of one of the world’s premier science institutions.
Ronald Daniels is 60, he's been the Independent Director of BridgeBio Pharma Inc since 2020. There are 8 older and 13 younger executives at BridgeBio Pharma Inc. The oldest executive at BridgeBio Pharma Inc is Dr. Charles J. Homcy M.D., 73, who is the Chairman of Pharmaceuticals & Lead Director.
Ronald's mailing address filed with the SEC is C/O BRIDGEBIO PHARMA, INC., 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304.
Over the last 5 years, insiders at BridgeBio Pharma Inc have traded over 409,396,563$ worth of BridgeBio Pharma Inc stock and bought 12,280,644 units worth 209,241,115$ . The most active insiders traders include Global Investors Lp Viking ...、Andrew Lo、Genetic Disorder L.P.Kkr Ge.... On average, BridgeBio Pharma Inc executives and independent directors trade stock every 12 days with the average trade being worth of 4,173,197$. The most recent stock trade was executed by Neil Kumar on 16 August 2024, trading 55,537 units of BBIO stock currently worth 1,554,481$.
we focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting r&d with expert capabilities and placing them in a value maximizing corporate structure.
BridgeBio Pharma Inc executives and other stock owners filed with the SEC include: